Lyell Immunopharma, Inc. · NASDAQ:LYEL

Innovative Cellular Therapeutics Holdings Ltd sold 10 Lyell Immunopharma, Inc. shares (Form 4)

Traded Jul 16, 2026 · Filed Jul 17, 2026

On Jul 16, 2026, Innovative Cellular Therapeutics Holdings Ltd (10% owner) sold 10 Lyell Immunopharma, Inc. shares at US$13.73 for US$137 under a trading plan, leaving 2,857,490 shares. Filed Jul 17, 2026 (Form 4).

Sold
10 shares
Price
US$13.73
Value
US$137
Holding after
2,857,490 shares
Trading plan
Yes (Made under a plan set in advance)
Role
10% owner

The filing in full

DateSecurityTransactionSharesPriceHolding afterOwnership
Jul 16, 2026Common StockSale10US$13.732,857,490Direct

Source

View original at SEC

Related